#TenpointTherapeutics is set to join the #USmarket for drugs to treat #presbyopia, taking on rival therapies from #AbbVie, #OrasisPharma, and #LENZTherapeutics, after getting FDA approval for its #Yuvezzi product.
Tenpoint eyes presbyopia drug launch after FDA nod
Tenpoint is set to join the US market for drugs to treat presbyopia, taking on rival therapies from AbbVie, Orasis Pharma, and LENZ Therapeutics.
buff.ly
January 29, 2026 at 4:30 PM
#TenpointTherapeutics is set to join the #USmarket for drugs to treat #presbyopia, taking on rival therapies from #AbbVie, #OrasisPharma, and #LENZTherapeutics, after getting FDA approval for its #Yuvezzi product.
Funding Raises: #Anthropic +$10B; #CoreWeave $2B; #Waabi $750M; #RedwoodMaterials $425M; #RicursiveIntelligence $300M; #Decagon $250M; #UpwindSecurity $250M; #TenpointTherapeutics $235M; #Synthesia $200M; #UpscaleAI $200M; #FlappingAirplanes $180M; #Inferact $150M; #PaleBlueDotAI $150M
January 30, 2026 at 6:05 PM
Funding Raises: #Anthropic +$10B; #CoreWeave $2B; #Waabi $750M; #RedwoodMaterials $425M; #RicursiveIntelligence $300M; #Decagon $250M; #UpwindSecurity $250M; #TenpointTherapeutics $235M; #Synthesia $200M; #UpscaleAI $200M; #FlappingAirplanes $180M; #Inferact $150M; #PaleBlueDotAI $150M